Plunkett Research Online: GeNeuro

GENEURO (GNRRF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

GeNeuro SA is a clinical-stage biopharmaceutical company. The company is developing a new approach to the treatment of autoimmune diseases, including multiple sclerosis and other diseases associated with human endogenous retroviruses (HERV). Its lead therapeutic candidate is GNbAC1 which is a humani.....


GENEURO

Ticker: GNRRF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 41 227945085
Fax:
Address: 18, chemin des Aulx
Geneva, 1228 Switzerland

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

GeNeuro SA is a clinical-stage biopharmaceutical company. The company is developing a new approach to the treatment of autoimmune diseases, including multiple sclerosis and other diseases associated with human endogenous retroviruses (HERV). Its lead therapeutic candidate is GNbAC1 which is a humani.....See More See More

$USD, In whole numbers2020201920182017201620152014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture